IDEAYA Biosciences IDYA
NASDAQ IDYA
$32.72 +0.97 (+3.04%)
At close: Nov 11, 2026 · 4:00 PM EST

IDEAYA Biosciences (IDYA) Change in Accrued Expenses (2018 - 2026)

Updated

IDEAYA Biosciences' Change in Accrued Expenses was $21.22 million in Q3 2026, up 182.6% from $7.51 million a year earlier and up 172.2% from the prior quarter.

Analysis

IDEAYA Biosciences (IDYA) Change in Accrued Expenses (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, IDEAYA Biosciences' Change in Accrued Expenses was $26.94 million through Sep 30, 2026, up 53.9% year-over-year; for FY2025, it was $10.43 million, down 3.4% from FY2024.

  • Change in Accrued Expenses shows a five-year compound annual growth rate of 28.4% (FY2020 to FY2025).
  • In earlier years, Change in Accrued Expenses was $10.79 million in FY2024 (+560.2%), $1.64 million in FY2023 (-64.2%), $4.57 million in FY2022 (+8.5%) and $4.21 million in FY2021 (+40.8%).
  • The Q3 2026 figure marks the highest quarterly Change in Accrued Expenses in data going back to Q3 2018.
  • Compared with a year earlier, Change in Accrued Expenses was higher in three of the last six quarters, with growth averaging 59.9%.
  • The best year-over-year quarter for Change in Accrued Expenses over five years was Q4 2023 (growth of 668.1%); the worst was Q4 2021 (a decline of 73.6%).
  • Per Business Quant data, IDYA's Change in Accrued Expenses in the three quarters before Q3 2026 was $7.79 million (Q2 2026), $2.73 million (Q1 2026) and -$4.8 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accrued Exp. (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 2.41 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 983.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -87.00 Mn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 756.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 IDEAYA Biosciences 3.07 Bn 90.55 Mn - 21.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 21.22 Mn
Jun 30, 2026 7.79 Mn
Mar 31, 2026 2.73 Mn
Dec 31, 2025 -4.80 Mn
Sep 30, 2025 7.51 Mn
Jun 30, 2025 4.84 Mn
Mar 31, 2025 2.88 Mn
Dec 31, 2024 2.27 Mn
Sep 30, 2024 2.90 Mn
Jun 30, 2024 6.90 Mn
Mar 31, 2024 -1.27 Mn
Dec 31, 2023 2.48 Mn
Sep 30, 2023 2.41 Mn
Jun 30, 2023 -2.84 Mn
Mar 31, 2023 -419,000.00
Dec 31, 2022 323,000.00
Sep 30, 2022 1.15 Mn
Jun 30, 2022 2.96 Mn
Mar 31, 2022 140,000.00
Dec 31, 2021 476,000.00
API Access

IDEAYA Biosciences Change in Accrued Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=IDYA&period=max&api_key=YOUR_API_KEY